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Acute acalculous cholecystitis is a rare complication in the treatment of acute myeloblastic leukemia.
Diagnosis of acute acalculous cholecystitis remains difﬁcult during neutropenic period. We present two
acute myeloblastic leukemia patients that developed acute acalculous cholecystitis during chemother-
apy-induced neutropenia. They suffered from fever, vomiting and acute pain in the epigastrium. Ultra-
sound demonstrated an acalculous gallbladder. Surgical management was required in one patient and
conservative treatment was attempted in the other patient. None treatment measures were effective and
two patients died. Acute acalculous cholecystitis is a serious complication in neutropenic patients. Earlier
diagnosis could have expedited the management of these patients.
& 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Acute acalculous cholecystitis (ACC) is deﬁned as an acute ne-
croinﬂammatory disease of the gallbladder in the absence of
cholelithiasis and has a multifactorial pathogenesis [1]. ACC has
very rarely been described in patients undergoing myelosuppres-
sive chemotherapy for acute myeloblastic leukemia (AML). As far
as the latter patients are concerned, expecting severe neutropenia
lasting for Z10 days, ACC is associated with signiﬁcant morbidity
and mortality [2]. Clinical diagnosis of ACC remains difﬁcult in
these patients’ populations, but early diagnosis and intervention
can boost prognosis. We present two AML patients that developed
ACC during chemotherapy-induced neutropenia.
Case report 1: A 21-year-old male was admitted to our hospital
for AML. The patient started chemotherapy with cytarabine
200 mg/m2 in a 24 h infusion through days 1 to 7 and idarubicin
12 mg/m2 (days 1,2,3). In neutropenic period, he developed in-
vasive pulmonary aspergillosis treated with voriconazole and
Stenotrophomonas maltophilia bacteremia that resolved with broad
spectrum antibiotics. The bone marrow examination on the 25th
days of induction showed persisting inﬁltration with 50% blasts.
The patient, then, underwent a second course of induction che-
motherapy with high dose of cytarabine 6 g/m2 (days 1,2,3) andLtd. This is an open access article u
niversity of Sfax, Hedi Chaker
74240549.Metoxantrone 12 mg/m2 (days 1,2,3). He received voriconazole
during chemotherapy for secondary prophylaxis of probable in-
vasive aspergillosis. On day 9 of the second course, he presented
febrile neutropenia that has been aggravated by septic shock.
Broad spectrum antibiotic regimen and intravenous crystalloid
ﬂuid were administered. The values of peripheral blood pressure
responded well to ﬂuids. Enterobacter cloacae were detected in
peripheral blood. However, the patient was still febrile. On day 20,
he was diagnosed with acute pain in the right upper quadrant
accompanied by vomiting. His leukocyte count was 0.5109/L and
absolute neutrophil count was 0.0109/L. C-reactive protein was
260 mg/dL. His renal function was normal, and liver function tests
result showed cholestasis without cytolysis. Abdominal ultra-
sonography was performed and demonstrated acalculous gall-
bladder with overdistention, wall thickening (up to 5 mm). ACC
was diagnosed and the medical therapy continued (broad spec-
trum antibiotic regimen, intravenous ﬂuids, fasting). Nevertheless,
the patient’s condition deteriorated and on the next day, he pre-
sented abdominal contracture. A second abdominal ultrasound
demonstrated acalculous gallbladder with overdistention, wall
thickening (up to 11 mm) and pericholecystic ﬂuid (Fig. 1). The
patient was qualiﬁed for life-saving surgery. Open-cholecys-
tectomy was performed after platelet concentrate transfusions.
The intraoperative examination revealed a gangrenous acalculous
cholecystitis that had reached the cystic duct and an under hepatic
blade. Histopathological evidence demonstrated gangrenous cho-
lecystitis. In the postoperative period, a broad spectrum antibioticnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Ultrasound appearance of thickened wall gallbladder.
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continued. However, the patient was still febrile. Chest X-ray de-
monstrated an intensive bilateral pneumonia. Then, the patient
presented a respiratory distress syndrome and he died on post-
operative day 5.
Case report 2: A 52 year old female was followed up at our
hospital for AML. She was in remission after induction che-
motherapy. The course was complicated by invasive pulmonary
aspergillosis treated with Voriconazole. Then, she received a ﬁrst
course of consolidation. During neutropenic period, she presented
a bacteremia to Burkhaldaria cepacia. The patient was treated with
broad spectrum antibiotic. A second course of consolidation was
administrated with cytarabine 200 mg/m2 in a 24 h infusion
through days 1–7; daunorubicin 50 mg/m2 (days 1,2,3) and eto-
poside 100 mg/m2 in a 4-h infusion every 24 h from day 1 to day 5.
She received voriconazole during chemotherapy for secondary
prophylaxis of probable invasive aspergillosis. Nine days after
chemotherapy, the patient presented a febrile neutropenia with
worsening diarrhea, intermittent nausea, vomiting, and acute ab-
dominal pain. She received a combination of antibiotic therapy
and imipenem, amikacin. Blood cultures were negative. She re-
mained febrile. On the 21 day after the start of chemotherapy,
while the patient was under broad-spectrum antibiotic treatment,
the symptoms recurred; fever accompanied by vomiting and acute
pain in the right upper quadrant. Laboratory examination revealed
the following results: C-reactive protein increased to 450 mg/l,
absolute neutrophil count was 0.0109/L and platelets count
0.8109/L, accompanied by elevated blood levels of cholestatic
liver enzymes without cytolysis with a total bilirubin of 163 mi-
cromol [4–24 mmol]. Abdominal ultrasonography and computer
tomography conﬁrmed the diagnosis of ACC by showing gallblader
with overdistention, wall thickening (mm) and biliary sludge
(Fig. 2). ACC was diagnosed, and the medical therapy was con-
tinued (broad spectrum antibiotic regimen, intravenous ﬂuid,
fasting). However, the patient’s condition deteriorated and she
died by septic shock after 5 days of ACC diagnostic.Fig. 2. Computed axial tomography demonstrating thickening of2. Comments
The present two cases developed ACC during chemotherapy
induced neutropenic for AML. ACC is a relatively rare complication
in these patients’ population. It’s reported in 0.4% among all
neutropenic episodes of patients with acute leukemia or ag-
gressive lymphoma undergoing myelosuppressive chemotherapy
[3]. Clinically, AAC is difﬁcult to diagnose because the ﬁndings of
right upper-quadrant pain, fever, leukocytosis, and abnormal liver
tests are not speciﬁc. Diagnosis of ACC may be further prolonged
until the patient’s general condition worsens as a consequence of
gallbladder necrosis or perforation, as our two cases. Ultrasound is
an established valuable imaging method if cholecystitis is sus-
pected [4]. Computed tomography can be extremely useful in the
assessment of septic shock of unknown origin in this patient po-
pulation [4]. In the present two cases, we observed several factors
that were most likely responsible for ACC. These included che-
motherapy, neutropenia, fasting, fever, diarrhea and bacteremia.
The latter factors induced intracystic hemorrhage followed by
sudden exacerbation, which resulted in gangrenous cholecystitis
followed by perforative biliary peritonitis [2]. Similar ﬁnding was
observed in our ﬁrst case report. Voriconazole recommended for
treatment of invasive aspergillosis, were associated with sig-
niﬁcant increasing toxic adverse effect. Cholecystitis was reported
in few patients exposed to voriconazole medication [5]. Our two
patients were treated with voriconazole during the course of
chemotherapy. Voriconazole might have increased the risk of
cholecystitis in our two patients. The two prevailing treatment
options for AAC are cholecystostomy and/or cholecystectomy [2].
However, there was a hot debate as to its optimal effectiveness in
the treatment of ACC. Consequently, Cholecystostomy does not
offer a survival beneﬁt compared with cholecystectomy or no
surgical interventions in patients with ACC [6]. Several studies
have found improved outcomes in patients with cholecystectomy
compared with patients without surgical management [6]. Early
cholecystectomy eliminated the potential infection foci, andthe gallbladder with surrounding edema and inﬂammation.
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our ﬁrst case, the ultrasound image was suggestive of gall bladder
necrosis, with biliary perforation and this was conﬁrmed in in-
traoperative. In the second case, the operation wasn’t performed
urgently, and the patient died by septic shock. These two pre-
sented cases conﬁrm that ACC can progress into a very serious
condition with high risk of mortality if gangrene and perforation
developed.3. Conclusion
There are several risk factors for gallbladder-related surgical
emergencies in patients with acute leukemia. Although ACC is rare,
it should be added to be the list of main causes leading to acute
abdominal pain in neutropenic patients and unexplained fever.
These two cases at hand, also demonstrate that ACC is associated
with poor short term outcome in neutropenic patients. Early di-
agnosis and treatment may lead to better outcomes.Conﬂict of interest
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